Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001493152-26-029898

Director acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jerman Michael Allen Director 2026-05-04 Grant or award +50,000 180,411 D: show line 1 in the form
Loading xslF345X06/ownership.xml…